Dipeptidyl peptidase-4 inhibitor

A class of antidiabetic drugs.

Phase of research

Potential treatment - clinical evidence

How it helps

Other treatment

Drug status

Used to treat other disease

0
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

Dipeptidyl Peptidase-4 inhibitors (DPP4i) are a group of drugs used to control high blood sugar in adults with type 2 diabetes. Some examples of DPP4i include sitagliptin or haloperidol. DPP4i usage has been linked to less severe COVID-19 cases. No significant differences were noted between patients in the use of metformin and DPP4i (Bramante et al., 2022).

Dipeptidyl peptidase-4 inhibitor on Wikipedia


Synonyms

DPP4i